PQ 269
269. Deputy Louise O'Reilly asked the Minister for Health the terms of reference for the new rare diseases medicinal product technology review committee; the formal role it will have in the reimbursement process for rare and ultra rare diseases; and if he will make a statement on the matter. [10894/18]
Introduced
8 March 2018
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 March 2018
Summary
269. Deputy Louise O'Reilly asked the Minister for Health the terms of reference for the new rare diseases medicinal product technology review committee; the formal role it will have in the reimbursement process for rare and ultra rare diseases; and if he will make a statement on the matter. [10894/18]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Rare Diseases
Rare Diseases
xml · EN · 8 March 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2018-03-08/269/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2018-03-08/pq_269